Figure S2 from Denfivontinib Activates Effector T Cells Through the NLRP3 Inflammasome, Yielding Potent Anticancer Effects by Combination with Pembrolizumab
Dong Kwon Kim, Chun‐Bong Synn, Wongeun Lee, Ha-Ni Jo et autres
0 citations
Mi Hyun Kim
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
18Publications signalées
0Citations signalées
0Affiliations récentes
Les domaines associés
Inflammasome and immune disordersCancer Immunotherapy and BiomarkersImmune cells in cancerPhagocytosis and Immune RegulationPsoriasis: Treatment and Pathogenesis
Les publications récentes
Figure S16 from Denfivontinib Activates Effector T Cells Through the NLRP3 Inflammasome, Yielding Potent Anticancer Effects by Combination with Pembrolizumab
Dong Kwon Kim, Chun‐Bong Synn, Wongeun Lee, Ha-Ni Jo et autres
0 citations
Figure S6 from Denfivontinib Activates Effector T Cells Through the NLRP3 Inflammasome, Yielding Potent Anticancer Effects by Combination with Pembrolizumab
Dong Kwon Kim, Chun‐Bong Synn, Wongeun Lee, Ha-Ni Jo et autres
0 citations
Table S1 from Denfivontinib Activates Effector T Cells Through the NLRP3 Inflammasome, Yielding Potent Anticancer Effects by Combination with Pembrolizumab
Dong Kwon Kim, Chun‐Bong Synn, Wongeun Lee, Ha-Ni Jo et autres
0 citations
Figure S7 from Denfivontinib Activates Effector T Cells Through the NLRP3 Inflammasome, Yielding Potent Anticancer Effects by Combination with Pembrolizumab
Dong Kwon Kim, Chun‐Bong Synn, Wongeun Lee, Ha-Ni Jo et autres
0 citations
Figure S12 from Denfivontinib Activates Effector T Cells Through the NLRP3 Inflammasome, Yielding Potent Anticancer Effects by Combination with Pembrolizumab
Dong Kwon Kim, Chun‐Bong Synn, Wongeun Lee, Ha-Ni Jo et autres
0 citations
Figure S1 from Denfivontinib Activates Effector T Cells Through the NLRP3 Inflammasome, Yielding Potent Anticancer Effects by Combination with Pembrolizumab
Dong Kwon Kim, Chun‐Bong Synn, Wongeun Lee, Ha-Ni Jo et autres
0 citations
Figure S4 from Denfivontinib Activates Effector T Cells Through the NLRP3 Inflammasome, Yielding Potent Anticancer Effects by Combination with Pembrolizumab
Dong Kwon Kim, Chun‐Bong Synn, Wongeun Lee, Ha-Ni Jo et autres
0 citations
Figure S10 from Denfivontinib Activates Effector T Cells Through the NLRP3 Inflammasome, Yielding Potent Anticancer Effects by Combination with Pembrolizumab
Dong Kwon Kim, Chun‐Bong Synn, Wongeun Lee, Ha-Ni Jo et autres
0 citations
Figure S11 from Denfivontinib Activates Effector T Cells Through the NLRP3 Inflammasome, Yielding Potent Anticancer Effects by Combination with Pembrolizumab
Dong Kwon Kim, Chun‐Bong Synn, Wongeun Lee, Ha-Ni Jo et autres
0 citations
Figure S5 from Denfivontinib Activates Effector T Cells Through the NLRP3 Inflammasome, Yielding Potent Anticancer Effects by Combination with Pembrolizumab
Dong Kwon Kim, Chun‐Bong Synn, Wongeun Lee, Ha-Ni Jo et autres
0 citations
Figure S14 from Denfivontinib Activates Effector T Cells Through the NLRP3 Inflammasome, Yielding Potent Anticancer Effects by Combination with Pembrolizumab
Dong Kwon Kim, Chun‐Bong Synn, Wongeun Lee, Ha-Ni Jo et autres
0 citations
BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.